Safety - Esthetician Leadership Today

Florida's New BBL Safety Law Praised by Cosmetic Surgeons

MedEsthetics

OCTOBER 11, 2023

Florida's new law mandating the use of ultrasound guidance during gluteal fat grafting procedures has been praised by the AACS and ABCS for implementing improved patient safety measures without limiting surgeons' right to practice.

Safety

Safety Legal

Cosmetic Dermatology in the Digital Age: How to Harness Technology and Uphold Safety and Ethics

The Dermatology Digest

DECEMBER 6, 2024

Cosmetic dermatologists must learn to harness technology while upholding the core values of safety, ethics, and patient satisfaction, writes Neelam Vashi, MD, an Associate Professor of Dermatology at Boston University Chobanian & Avedisian School of Medicine in Boston, MA, in the Journal of Clinical Medicine.

Ethics

Ethics Safety Social Media Technology

Safety Concerns About Cosmetic Misuse of Ozempic Spark Widespread Controversy

MedEsthetics

JULY 19, 2024

Concerns about counterfeit Ozempic products and potential long-term effects has resulted in some pushback against GLP-1 drugs.

Safety

Safety Treatments

FDA Updates Recommendations on Dermal Fillers for Patient Safety

MedEsthetics

OCTOBER 30, 2023

The FDA recommends against the use of soft tissue fillers to increase breast size and the use of permanent fillers like silicone for cosmetic treatment, among other new guidelines.

Safety

Safety Treatments Injections

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

Dermatology Times

SEPTEMBER 26, 2023

Ruth Ann Vleugels, MD, and Christopher Bunick, MD, agreed that the long-term safety data for JAK inhibitors makes them preferable to systemic steroids.

Safety

Safety Dermatitis Treatments

Texas Medspa IV Therapy Death: Dangers of Improper Supervision & Safety Protocols

MedEsthetics

OCTOBER 30, 2023

Following a patient's death at Luxe Med Spa, the Texas Medical Board has declared that the spa's medical director Michael Gallagher, M.D. is a continuing threat to public welfare due to the doctor's improper supervision of IV treatments.

Med Spa

Med Spa Safety Therapy Medical

Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial

Dermatology Times

MAY 16, 2024

Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.

Safety

Safety Sustainability

Analyzing Efficacy and Safety in Diverse Clinical Trials: New Roflumilast Data

Dermatology Times

OCTOBER 1, 2024

After releasing promising data from several clinical trials, Burnett discussed the importance of studying efficacy and safety across diverse populations.

Safety

Safety Clinic

Vice & Virtue Launches Endocrine Conscious Skin Care for Skin Safety at the Micro Level

MedEsthetics

NOVEMBER 5, 2024

Vice & Virtue's new skin care line addresses the epidemic of dangerous endocrine-disrupting chemicals with its commitment to providing skin safety at the micro level.

Safety

Poster Detailing Safety of JAK Inhibitors Wins Award at AAD Annual Meeting

Dermatology Times

MARCH 18, 2024

Henry Lim, MD, shares insights on JAK inhibitor safety and the poster presented at the AAD Annual Meeting

Safety

Long-Term Safety of Dupilumab in Adults with Moderate to Severe Atopic Dermatitis

Dermatology Times

NOVEMBER 2, 2023

The results from this 5-year open-label extension trial affirm the safety of dupilumab in adults with moderate to severe AD.

Safety

Safety Dermatitis

Navigating Pregnancy, Dermatology, and Drug Safety

Dermatology Times

FEBRUARY 19, 2024

Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.

Safety

Safety Dermatology Clinic Medical

Misuse of At-home Medical Devices Tops ECRI's List of Technology Safety Hazards

MedEsthetics

APRIL 11, 2024

Safety hazards can develop when medical devices that are designed for use by healthcare professionals are too complex for typical patient use.

Safety

Safety Medical Technology

Discover the Benefits of Dermaplaning: The Secret to Radiant Skin

Kim Gallo Esthetics

SEPTEMBER 26, 2024

As an experienced esthetician, I ensure each session is tailored to meet the unique needs of your skin, using precise techniques to maximize benefits while maintaining safety. Safety and Considerations Is Dermaplaning Safe? Improper techniques or instruments can lead to adverse effects such as scarring or infection.

Dermaplaning

Dermaplaning Skincare Routine Makeup Exfoliation

The Importance of Personal Alarms for Seniors: Ensuring Safety and Independence

Spa Industry Association

JUNE 24, 2024

Ensuring the safety and well-being of seniors is a priority for many families. Personal alarms offer a practical solution by providing an immediate way to call for help in emergency situations, enhancing safety and peace of mind. As seniors age, the risk of falls and medical emergencies increases.

Safety

Safety Medical

Best Practices To Ensure Client and Employee Safety in Spas

Spa Industry Association

MARCH 28, 2024

Why Spa Safety Is Important Establishments that serve the public have to protect their customers and employees. Continue reading Best Practices To Ensure Client and Employee Safety in Spas at Spa Industry Association. Learn how to equip your spa to be a literal haven for your team and anyone who walks through its doors.

Safety

Phase 2b Trial Reinforces Zasocitinib’s Safety Profile

Dermatology Times

OCTOBER 8, 2024

Melinda Gooderham, MSc, MD, FRCPC, emphasized the significance of the study’s results, showcasing stable laboratory parameters over a 12-week trial.

Safety

Mold in Skincare: When an Increase in Trends Leads to a Decrease in Testing

Renee Rouleau

JULY 28, 2023

This really got me thinking—as Head of New Product Development at my company, it’s always been my responsibility to ensure the safety and quality of our products. This is why it’s incredibly important for manufacturers to follow proper safety and cleaning procedures to prevent contamination.

Skincare

Skincare Branding Safety Esthetician

Medical Grade Skincare vs. Over-the-Counter Products: What’s the Difference?

Kim Gallo Esthetics

MAY 31, 2023

Higher quality Because medical-grade products are developed and tested by medical professionals, they are held to higher standards and must pass rigorous tests for safety and performance. FDA regulated Medical-grade skincare products are regulated by the FDA to ensure they meet safety and quality standards.

Medical Grade Skincare

Medical Grade Skincare Medical Skincare Skincare Brands

New Petition Calls for Stronger Safety Warnings on Botox Labels

MedEsthetics

JANUARY 8, 2024

The petition was filed on behalf of Public Citizen, a nonprofit consumer advocacy organization, and builds on a 2008 Public Citizen petition that asked the FDA to require the addition of the black-box warning on the labeling of Botox and related drugs.

Safety

Safety Injections

Fostering Patient Wellness: Prioritizing Safety and Education in PDE4 Utilization

Dermatology Times

JANUARY 9, 2024

Experts in dermatology highlight the crucial role of setting treatment response expectations and stress the need for discussions on managing mild plaque psoriasis, highlighting the utilization of systemic therapies in this context.

Safety

Safety Education Therapy Management

20+ Years in the Skincare Industry: Advice From an Esthetician

Kim Gallo Esthetics

FEBRUARY 27, 2024

The accessibility of tools and treatments prompts questions about their efficacy and safety, reminding us to trust professionals for guidance and comprehensive understanding. While there are at-home microneedling options available, it's best to seek professional treatment for optimal results and safety.

Skincare

Skincare Esthetician Skincare Routine Chemical Peels

Safety, Efficacy, and Treatment Adherence in Young Patients With Vitiligo

Dermatology Times

DECEMBER 12, 2024

Karan Lal, DO, MS, FAAD, discusses how to balance safety and efficacy considerations while promoting treatment adherence in young vitiligo patients, focusing on the unique challenges and monitoring requirements for this vulnerable population.

Safety

Safety Treatments

Iain Stuart, PhD: VYN202 Positive Safety and Tolerability in Phase 1a

Dermatology Times

SEPTEMBER 24, 2024

VYNE recently announced positive results for its novel oral small molecule BD2-selective BET inhibitor in a single-ascending dose clinical trial.

Safety

Safety Clinic

Can I Ask About Gun Ownership for My Safety?

Dermatology Times

DECEMBER 21, 2023

Dr Derm has recently been sued by a patient for simply asking the question “Do you own a gun?” He seeks legal advice.

Legal

Legal Safety

Meet ASDSA’s 2024 Patient Safety Hero Award Honorees

The Dermatology Digest

OCTOBER 16, 2024

_Ann Haas, MD, and Jerome Potozkin, MD, are being honored with the Patient Safety Hero Award for their efforts on behalf of the California Society of Dermatology and Dermatologic Surgery to protect physicians’ ability to mix and dilute drugs in-office. We appreciate their hard work and dedication to promoting and protecting patient safety.

Safety

Safety Surgery Office Dermatology

Safety vs Efficacy: What AD Treatments Can Be Used in Pediatric Patients?

Dermatology Times

JUNE 10, 2024

Amy Paller, MD, reviews the various types of therapeutics available and coming soon for pediatric atopic dermatitis and how she decides what treatment approach is best for each patient.

Safety

Safety Treatments Dermatitis

Mobile Health Technologies In Studies of Actinic Keratosis Do Not Compromise Patient Safety, Research Article Says

Dermatology Times

APRIL 19, 2024

Researchers examined local skin reactions of a topical gel inhibiting cytosolic phospholipase A2 both in-clinic and remotely.

Technology

Technology Safety Clinic

FRONTIER-2 Study Evaluates Safety and Efficacy of Tozorakimab in Patients with AD

Dermatology Times

NOVEMBER 19, 2024

Patients with moderate to severe atopic dermatitis saw the most improvement after taking 600 mg of tozorakimab.

Safety

Safety Dermatitis

Late-Breaking Data: Long-Term Safety and Efficacy of Largest Prurigo Nodularis Study Ever Conducted

Dermatology Times

MARCH 10, 2024

Shawn Kwatra, MD, presented late-breaking data at AAD 2024 on the largest prurigo nodularis and nemolizumab clinical trial, OLYMPIA.

Safety

Safety Clinic

Late-Breaking Data: 40-Week Efficacy and Safety of Oral Povorcitinib for Prurigo Nodularis

Dermatology Times

OCTOBER 1, 2024

Shawn Kwatra, MD, presented the Incyte data at EADV 2024.

Safety

Phase 3 Data Confirms Long-Term Efficacy, Sustained Safety of Oral Remibrutinib for CSU

Dermatology Times

MAY 30, 2024

Novartis announced late-breaking data for the BTK inhibitor at the 2024 European Academy of Allergy and Clinical Immunology Congress.

Sustainability

Sustainability Safety Clinic

Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis

Dermatology Times

SEPTEMBER 9, 2024

The oral TYK2 inhibitor demonstrated biologic-level efficacy.

Safety

VYN201 for Vitiligo: Phase 1b Study Confirms Safety

Dermatology Times

NOVEMBER 1, 2024

VYNE Therapies announces that aNSV patients saw disease improvement without serious adverse effects.

Safety

Safety Therapy

5-Year Safety Data Leaves Investigators Optimistic in Upadacitinib for AD Management

Dermatology Times

DECEMBER 11, 2023

Christopher Bunick, MD, PhD, presented the research during a late-breaking research session during the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Safety

Safety Management Dermatitis

Bimekizumab Demonstrates Safety and Efficacy in Elderly Patients with Psoriasis

Dermatology Times

OCTOBER 10, 2024

The IL-17 inhibitor demonstrated biologic-level efficacy in moderate to severe plaque psoriasis.

Safety

ACAAI Presentation Highlights Roflumilast’s Efficacy and Safety

Dermatology Times

OCTOBER 24, 2024

Findings from 2 phase 3 trials indicate that ZORYVE cream significantly improves both clinical outcomes and quality of life in patients with mild to moderate atopic dermatitis.

Safety

Safety Dermatitis Clinic

52-Week Study Reveals Efficacy and Safety of Apremilast for Japanese Patients with Palmoplantar Pustulosis

Dermatology Times

NOVEMBER 7, 2024

Apremilast led to a 75% improvement in PPPASI-75 in a significant portion of patients by week 16, with these improvements maintained through week 52.

Safety

Late-Breaking Data: Long-Term Safety and Efficacy of Delgocitinib Cream for Chronic Hand Eczema

Dermatology Times

MARCH 10, 2024

Melinda Gooderham, MSc, MD, FRCPC, provided insights into the significance of the DELTA 3 extension data presented at AAD 2024.

Eczema

Eczema Safety

Dermavant Shares Positive Safety and Efficacy Data From Analysis of ADORING Program for Atopic Dermatitis

Dermatology Times

JANUARY 11, 2024

The additional efficacy data highlights tapinarof cream 1% and its impact on EASI, PP-NRS, ViGA-AD, and more.

Safety

Safety Dermatitis

Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Dermatology Times

APRIL 16, 2024

A study demonstrated the favorable efficacy and safety profiles of secukinumab in patients with severe HS for up to 52 weeks.

Safety

South Korea Study Delves Into Safety Insights for JAK Inhibitors for Atopic Dermatitis

Dermatology Times

DECEMBER 18, 2023

Pusan National University published the review in light of the growing body of JAK inhibitors in the AD space.

Safety

Safety Dermatitis

Evaluating the Efficacy and Safety of Organic Acids in Chemical Peels for Acne

Dermatology Times

NOVEMBER 8, 2023

Despite how widely used these acids often are, there is still a lack of general consensus for which are the most effective in patients with acne-prone skin.

Chemical Peels

Chemical Peels Safety

Phase 1b Data for Topical Pravibismane in Diabetic Foot Ulcer Infection Demonstrates Favorable Effects and Safety

Dermatology Times

APRIL 8, 2024

Data was recently published in the International Wound Journal supporting positive outcomes in moderate or severe ulcers.

Safety

Florida's New BBL Safety Law Praised by Cosmetic Surgeons

Cosmetic Dermatology in the Digital Age: How to Harness Technology and Uphold Safety and Ethics

Trending Sources

Safety Concerns About Cosmetic Misuse of Ozempic Spark Widespread Controversy

FDA Updates Recommendations on Dermal Fillers for Patient Safety

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

Texas Medspa IV Therapy Death: Dangers of Improper Supervision & Safety Protocols

Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial

Analyzing Efficacy and Safety in Diverse Clinical Trials: New Roflumilast Data

Vice & Virtue Launches Endocrine Conscious Skin Care for Skin Safety at the Micro Level

Poster Detailing Safety of JAK Inhibitors Wins Award at AAD Annual Meeting

Long-Term Safety of Dupilumab in Adults with Moderate to Severe Atopic Dermatitis

Navigating Pregnancy, Dermatology, and Drug Safety

Misuse of At-home Medical Devices Tops ECRI's List of Technology Safety Hazards

Discover the Benefits of Dermaplaning: The Secret to Radiant Skin

The Importance of Personal Alarms for Seniors: Ensuring Safety and Independence

Best Practices To Ensure Client and Employee Safety in Spas

Phase 2b Trial Reinforces Zasocitinib’s Safety Profile

Mold in Skincare: When an Increase in Trends Leads to a Decrease in Testing

Medical Grade Skincare vs. Over-the-Counter Products: What’s the Difference?

New Petition Calls for Stronger Safety Warnings on Botox Labels

Fostering Patient Wellness: Prioritizing Safety and Education in PDE4 Utilization

20+ Years in the Skincare Industry: Advice From an Esthetician

Safety, Efficacy, and Treatment Adherence in Young Patients With Vitiligo

Iain Stuart, PhD: VYN202 Positive Safety and Tolerability in Phase 1a

Can I Ask About Gun Ownership for My Safety?

Meet ASDSA’s 2024 Patient Safety Hero Award Honorees

Safety vs Efficacy: What AD Treatments Can Be Used in Pediatric Patients?

Mobile Health Technologies In Studies of Actinic Keratosis Do Not Compromise Patient Safety, Research Article Says

FRONTIER-2 Study Evaluates Safety and Efficacy of Tozorakimab in Patients with AD

Late-Breaking Data: Long-Term Safety and Efficacy of Largest Prurigo Nodularis Study Ever Conducted

Late-Breaking Data: 40-Week Efficacy and Safety of Oral Povorcitinib for Prurigo Nodularis

Phase 3 Data Confirms Long-Term Efficacy, Sustained Safety of Oral Remibrutinib for CSU

Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis

VYN201 for Vitiligo: Phase 1b Study Confirms Safety

5-Year Safety Data Leaves Investigators Optimistic in Upadacitinib for AD Management

Bimekizumab Demonstrates Safety and Efficacy in Elderly Patients with Psoriasis

ACAAI Presentation Highlights Roflumilast’s Efficacy and Safety

52-Week Study Reveals Efficacy and Safety of Apremilast for Japanese Patients with Palmoplantar Pustulosis

Late-Breaking Data: Long-Term Safety and Efficacy of Delgocitinib Cream for Chronic Hand Eczema

Dermavant Shares Positive Safety and Efficacy Data From Analysis of ADORING Program for Atopic Dermatitis

Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

South Korea Study Delves Into Safety Insights for JAK Inhibitors for Atopic Dermatitis

Evaluating the Efficacy and Safety of Organic Acids in Chemical Peels for Acne

Phase 1b Data for Topical Pravibismane in Diabetic Foot Ulcer Infection Demonstrates Favorable Effects and Safety

Stay Connected